Stay updated on Subcutaneous Lirentelimab in Urticaria: Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Lirentelimab in Urticaria: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Lirentelimab in Urticaria: Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    No additions or deletions were detected; the study details page remains consistent across views. The page continues to present trial information, locations, eligibility criteria, and outcomes.
    Difference
    0.3%
    Check dated 2025-11-03T12:48:50.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    34 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and the new government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If there are no other changes, this is the main shift.
    Difference
    3%
    Check dated 2025-10-05T17:42:12.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    Updated to Revision v3.1.0 and removal of multiple drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs), indicating content pruning in the drug-safety area and a new version tag.
    Difference
    0.3%
    Check dated 2025-09-28T11:17:05.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    - Updated revision to v3.0.2 and removed the Back to Top element. - There are no significant changes to core content or critical information such as pricing, stock, or time slots.
    Difference
    0.2%
    Check dated 2025-09-14T00:51:07.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.2%
    Check dated 2025-09-06T21:24:28.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has updated its facility name and location details, including the addition of specific topics related to drug safety and counterfeit drugs, while removing previous location references and certain related medical topics.
    Difference
    2%
    Check dated 2025-08-30T15:59:16.000Z thumbnail image

Stay in the know with updates to Subcutaneous Lirentelimab in Urticaria: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Lirentelimab in Urticaria: Clinical Trial page.